US Broker Ratings

AptarGroup, Inc. (ATR) Stock Analysis: 25.64% Potential Upside Sparks Investor Interest

AptarGroup, Inc. (NYSE: ATR), a prominent player in the healthcare sector specializing in medical instruments and supplies, is catching the eye of investors with its promising potential upside of 25.64%...

HCA Healthcare, Inc. (HCA) Stock Analysis: Navigating a 9.68% Potential Upside Amid Strong Revenue Growth

HCA Healthcare, Inc. (NYSE: HCA) stands as a formidable player in the U.S. healthcare sector, commanding a market capitalization of $91.7 billion. As an investor, keeping an eye on this..

Viatris Inc. (VTRS) Stock Analysis: Unveiling a 12.6% Potential Upside Amidst Strong Cash Flow

Viatris Inc. (NASDAQ: VTRS), with its extensive global footprint and diverse pharmaceutical portfolio, has emerged as a notable player in the healthcare sector. As the company continues to expand its..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Unveiling a 40% Potential Upside in the Biotech Arena

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stands as a formidable player in the biotechnology sector, renowned for its focus on developing therapies for life-threatening rare diseases. With a market capitalization of..

Alcon Inc. (ALC) Stock Analysis: Tapping into a 21.6% Upside Potential in Healthcare Innovation

Alcon Inc. (NYSE: ALC), a global leader in eye care, presents an intriguing investment opportunity in the healthcare sector. Headquartered in Geneva, Switzerland, Alcon is renowned for its extensive range..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: A Biotech Powerhouse with Robust Revenue Growth and Strong Analyst Support

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, has been capturing investor attention with its impressive market performance and promising growth trajectory. With a market cap..

Veeva Systems Inc. (VEEV) Stock Analysis: Exploring Growth Potential with Analyst Ratings and Revenue Performance

Veeva Systems Inc. (NYSE: VEEV), a leading player in the healthcare sector, specifically within health information services, is capturing investor attention with its robust revenue growth and strong buy ratings...

DexCom, Inc. (DXCM) Stock Analysis: Exploring the 10.25% Potential Upside for Investors

DexCom, Inc. (NASDAQ: DXCM), a leader in the healthcare sector’s medical device industry, continues to capture investor attention with its innovative solutions in the diabetes management space. With a market..

Biogen Inc. (BIIB) Stock Analysis: Uncovering a Potential 13% Upside

Biogen Inc. (NASDAQ: BIIB), a prominent player in the healthcare sector, particularly in the drug manufacturing industry, is attracting investor attention with its robust portfolio and strategic collaborations. With a..

Qiagen N.V. (QGEN) Investor Outlook: Analyzing Growth Potential with an 8.24% Upside

For investors interested in the healthcare sector, Qiagen N.V. (NYSE: QGEN) presents an intriguing opportunity with its current market dynamics and potential upside. Headquartered in Venlo, the Netherlands, Qiagen operates..

Charles River Laboratories (CRL) Stock Analysis: Navigating Growth in Healthcare with a 1.26% Upside Potential

Charles River Laboratories International, Inc. (NYSE: CRL) stands at the forefront of the healthcare industry, particularly in diagnostics and research. With a robust market capitalization of $12.77 billion, this American..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Exploring a 16.52% Upside Potential

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a stalwart in the global pharmaceutical landscape, commands a significant presence in the healthcare sector, particularly in the arena of specialty and generic drug..

Molina Healthcare Inc (MOH) Stock Analysis: Evaluating a 6.45% Potential Upside with Market Dynamics

Molina Healthcare Inc (MOH) stands as a prominent player in the healthcare sector, focusing on providing managed healthcare services to low-income families and individuals. With a market capitalization of $10.25..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 21.77% Potential Upside in the Healthcare Sector

United Therapeutics Corporation (NASDAQ: UTHR), a key player in the healthcare sector, stands out as an intriguing investment opportunity for those focused on the drug manufacturing industry, particularly in specialty..

The Cooper Companies, Inc. (COO): Investor Outlook with a 9.41% Potential Upside

For investors looking to explore opportunities in the healthcare sector, The Cooper Companies, Inc. (NYSE: COO) presents a compelling case with a potential upside of 9.41%. With its diverse offerings..

Humana Inc. (HUM) Stock Analysis: Evaluating Growth Potential with a 8.16% Upside

Investors eyeing opportunities in the healthcare sector may want to give Humana Inc. (NYSE: HUM) a closer look. With a market capitalization of $46.23 billion, Humana stands as a formidable..

Labcorp Holdings Inc. (LH) Stock Analysis: A Strong Buy with 5.82% Upside Potential and Robust Growth Prospects

Labcorp Holdings Inc. (NYSE: LH), a leading player in the healthcare sector, stands out with its focus on diagnostics and research. Based in Burlington, North Carolina, Labcorp provides a wide..

Genmab A/S (GMAB) Stock Analysis: Promising 23% Upside Potential with Strong Buy Ratings

Genmab A/S (NASDAQ: GMAB), a leading biotechnology firm based in Denmark, is making waves in the healthcare sector with its innovative approach to antibody-based treatments. With a substantial market capitalization..

Johnson & Johnson (JNJ) Stock Analysis: Evaluating Its 5.11% Potential Upside

Johnson & Johnson (NYSE: JNJ), a titan in the healthcare sector with a market capitalization of $624.74 billion, has long been a staple in many investment portfolios. Known for its..

The Ensign Group, Inc. (ENSG) Stock Analysis: Navigating a 20% Potential Upside Amid Strong Revenue Growth

The Ensign Group, Inc. (NASDAQ: ENSG), a prominent player in the healthcare sector, particularly within the medical care facilities industry, presents a compelling investment opportunity for those eyeing robust growth..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds